You are on page 1of 5

CHAPTER 28

Small Intestine

1. Where is the largest number o hormone-producing cells Answer: B


ound in the body? he small intestine is the body’s largest reservoir o hormone-
A. T e pituitary producing cells. Multiple specialized cells within the intestinal
B. T e small intestine mucosa respond to luminal stimuli and secrete over 30 pep-
C. T e pancreas tide hormones which regulate the unctions o the intestine,
D. T e liver other organs in the gastro-entero-pancreato-biliary system,
the heart, and the brain (See Schwartz 10th ed., p. 1145.)

2. Which o the ollowing eatures is characteristic o the Answer: B


ileum, as opposed to the jejunum? he entire small intestine contains valvulae conniventes, also
A. T e presence o valvulae conniventes known as plicae circularis. he jejunum has larger vasa recta,
B. T e presence o Peyer patches a larger diameter, and a less atty mesentery. he ileum con-
C. Larger vasa recta tains prominent lymphoid ollicles called Peyer patches. (See
D. Less atty mesentery Schwartz 10th ed., p. 1138.)

3. Within the intestine, epithelial cells originate rom stem Answer: A


cells, proli erate in the crypts, and migrate up the villus in he high cellular turnover rate o enterocytes makes the small
2 to 5 days. T is process replaces cells that are removed due intestine susceptible to damage by inhibitors o proli eration
to apoptosis or ex oliation. T is rapid turnover makes the such as radiation and cytotoxic chemotherapy. (See Schwartz
small intestine susceptible to 10th ed., p. 1138.)
A. Radiation damage
B. Starvation
C. Exogenous steroids
D. Hypothermia

4. A pocket- or sock-like outpouching on the anti-mesenteric Answer: C


side o the distal ileum, called a Meckel diverticulum, is he embryonic gut communicates with the yolk sac by mean
caused by o the vitelline duct. Failure o this structure to obliterate by
A. Excessive traction on the intestine during childbirth. the end o gestation can result in a Meckel diverticulum. (See
B. Increased intraluminal pressure. Schwartz 10th ed., p. 1139.)
C. A persistent vitelline duct.
D. A mutation o the c-Mec gene.

5. How much uid normally enters the adult small intestine Answer: D
each day? Eight to nine liters o luid enters the small intestine daily,
A. 2 L o which over 80% is absorbed. his includes 2 L rom oral
B. 4 L intake, 1.5 L o saliva, 2.5 L o gastric juice, 1.5 L o biliopan-
C. 6 L creatic secretions, and 1 L o luid secreted by the small intes-
D. 8 L tine. (See Schwartz 10th ed., p. 1140.)

219
220
6. How are the digestion products o carbohydrates, such as Answer: B
glucose, galactose, and ructose, absorbed through the he three terminal products o carbohydrate digestion are
intestine? transported through the enterocyte brush border membrane
A. By passive di usion across enterocyte plasma membranes. via acilitative transporter proteins such as the sodium-glucose
B. By acilitated di usion via speci c transporters such as cotransporter 1 (SGL 1), glucose transporter 2 (GLU 2), and
sodium-glucose cotransporter 1 (SGL 1), glucose trans- glucose transporter 5 (GLU 5). here is evidence o overex-
porter 2 (GLU 2), and glucose transporter 5 (GLU 5). pression o these transporters, particularly SGL 1, in diabetes
C. By endocytosis o enterocytes on the villus. and obesity, and new therapeutic approaches or these condi-
D. By acilitated di usion through tight junctions between tions are designed to inhibit these transporters. (See Schwartz
enterocytes. 10th ed., p. 1141.)

7. What does the “enterohepatic circulation” re er to? Answer: C


A. T e superior mesenteric-portal venous circuit. Bile acids act as detergents which increase the solubility o lipid
B. T e secretion o cholesterol in the bile and its reabsorp- micelles which are taken up by the brush border membrane o
tion in the distal ileum. the jejunum, where over 90% o at is absorbed. he bile acids
C. T e secretion o bile acids by the liver and their reab- themselves remain in the intestinal lumen and are reabsorbed
sorption in the distal ileum. in the distal ileum where they enter the portal venous circula-
D. T e secretion o cholecystokinin by the jejunum and its tion and are re-secreted in the bile. (See Schwartz 10th ed.,
stimulation o bile ow. p. 1143.)

8. T e secretin-glucagon amily o gut hormones includes all Answer: A


o the ollowing structurally related peptides EXCEP Peptide hormones produced by enteroendocrine cells o
A. Somatostatin (SS ) the intestine are grouped into amilies based on their amino
B. Glucose-dependent insulinotropic polypeptide (GIP) acid structural similarity. he secretin-glucagon amily o
C. Glucagon-like peptide-1 (GLP-1) hormones includes glucose-dependent insulinotropic poly-
D. Vasoactive intestinal polypeptide (VIP) peptide (GIP), glucagon-like peptide-1 (GLP-1), vasoactive
intestinal polypeptide (VIP), peptide histidine isoleucine
(PHI), growth hormone-releasing hormone (GHRH), and
pituitary adenylyl cyclase-activating peptide (PACAP). (See
Schwartz 10th ed., p. 1145.)

9. T e most common cause o small bowel obstruction is Answer: D


A. Incarcerated hernia Intra-abdominal adhesions related to prior abdominal sur-
B. Crohn’s disease gery accounts or 75% o cases o small bowel obstruction.
C. Malignancy Cancer-related small bowel obstruction is almost always due
D. Postoperative adhesions to extrinsic compression or entrapment o the bowel by a pri-
mary or metastatic tumor; primary small bowel malignancies
are rare. (See Schwartz 10th ed., p. 1146.)

10. A closed-loop obstruction is particularly dangerous Answer: A


because A closed-loop obstruction, in which an intestinal segment is
A. Intraluminal pressure rises high enough to cause obstructed both proximally and distally, as in a volvulus, is
ischemia and necrosis. particularly dangerous because intraluminal pressure rises
B. T e obstruction is painless. quickly and can cause venous congestion and arterial obstruc-
C. Bacterial overgrowth results in sepsis. tion which leads to necrosis o the intestinal wall and per o-
D. T e obstructive segment is not apparent on imaging ration. It classically presents with “pain out o proportion to
studies. the physical exam,” and is usually apparent on C scan which
requently shows a U-shaped or C-shaped dilated bowel loop
associated with a radial distribution o mesenteric vessels
converging toward a torsion point. (See Schwartz 10th ed.,
p. 1147.)
221
11. T erapy o a small bowel obstruction usually consists o Answer: D
prompt surgical correction. In patients with no evidence Partial small bowel obstruction and early postoperative
o closed-loop obstruction, and in whom there is no ever obstruction can mimic ileus, and may respond to nonop-
or leukocytosis or tachycardia, a period o care ul obser- erative therapy. Crohn disease usually responds to medical
vation with nasogastric decompression may be success ul therapy, although recurrent obstruction is an indication or
in all o the ollowing conditions EXCEP surgical correction. Obstruction due to an internal hernia
A. Partial small bowel obstruction. requires prompt surgical intervention to avoid strangulation
B. Obstruction in the early postoperative period. and necrosis. (See Schwartz 10th ed., p. 1149.)
C. Obstruction due to Crohn disease.
D. Obstruction due to an internal hernia.

12. Interventions which may reduce the incidence and dura- Answer: C
tion o postoperative ileus include all o the ollowing Epidural analgesia (with reduced systemic narcotic admin-
EXCEP istration), avoiding excess intra- and postoperative luid
A. Epidural analgesia administration, and administration o alvimopan, a mu-
B. A m-opioid receptor antagonist opioid receptor antagonist, have all been associated with
C. Intravenous erythromycin reduced incidence and/or duration o postoperative ileus.
D. Avoiding excess intra- and postoperative uid Prokinetic agents such as metoclopramide and erythromycin
administration are rarely use ul. (See Schwartz 10th ed., p. 1153.)

13. Risk actors or the development o Crohn’s disease Answer: C


include all o the ollowing EXCEP he risk o having Crohn’s disease is two- to our old higher in
A. Having a amily member with Crohn’s disease Ashkenazi Jewish amilies, 15 times higher in amily members
B. Smoking o a patient with Crohn’s disease, and is increased in higher
C. Having Chinese ancestry socioeconomic groups, and among smokers. he incidence in
D. Having Ashkenazi Jewish ancestry China is 1% o the incidence in the United States, although
this number is increasing. (See Schwartz 10th ed., p. 1153.)

14. T e primary genetic de ect associated with Crohn’s dis- Answer: A


ease is a mutation o the NOD2 gene on chromosome 16. he protein product o the NOD2 gene mediates the innate
T is gene encodes or a protein product which immune response to microbial pathogens. A variety o de ects
A. Mediates the innate immune response to microbial in immune regulatory mechanisms such as overresponsive-
pathogens ness o mucosal cells to enteric lora-derived antigens can
B. Activates stellate cells to produce collagen lead to de ective immune tolerance and sustained in lamma-
C. Regulates the rate o crypt-to-villus enterocyte migration tion. (See Schwartz 10th ed., p. 1153.)
D. Mediates the production o enterocyte alkaline
phosphatase

15. In the resection o a stenotic area o intestine in a patient Answer: A


with Crohn’s disease, the best approach is here are no di erences in the recurrence rates or resection
A. A resection margin o 2 cm rom gross disease. with a 2-cm margin or a 12-cm margin rom gross disease.
B. A resection margin o 12 cm rom gross disease. he additional bowel lost may contribute to eventual short
C. A resection margin 2 cm rom microscopic disease on gut syndrome in a patient who requires multiple resections,
rozen section. so minimizing bowel loss is a priority. here is no bene it to
D. A resection margin 12 cm rom microscopic disease achieving rozen section negative margins in the resection o
on rozen section. Crohn’s strictures; positive margin resections have the same
recurrence rate as negative margin resections. he e ort to
obtain a rozen section negative margin carries the risk o
removing more intestine than is necessary. (See Schwartz
10th ed., p. 1157.)

16. T e ailure o an enterocutaneous stula to heal on a regi- Answer: D


men o total parenteral nutrition and antisecretory ther- Factors which prevent healing o an enterocutaneous istula
apy may be due to which o the ollowing? include oreign body, epithelialization o the istula tract,
A. A oreign body in the stula tract. downstream obstruction, radiation enteritis, associated in ec-
B. Epithelialization o the stula tract. tion (abscess or sepsis), malignancy, and a short (<2 cm)
C. Downstream obstruction o the stulized segment o istula tract. (See Schwartz 10th ed., p. 1158.)
intestine.
D. All o the above.
222
17. Which primary malignancy o the small intestine is most Answer: A
common? Adenocarcinomas o the duodenum are the most common
A. Adenocarcinoma o the duodenum primary small bowel malignancy and account or 35 to 50%
B. Carcinoid tumor o the ileum o the total. Lymphoma and gastrointestinal stromal tumors
C. Lymphoma o the jejunum (GIS s) o the small bowel are the least common and each
D. Gastrointestinal stromal tumor (GIS ) o the accounts or 10 to 15% o the total. (See Schwartz 10th ed.,
duodenum p. 1159.)

18. Adenocarcinoma o the duodenum is associated with Answer: B


what hereditary oncologic syndrome? Duodenal carcinoma is a late mani estation o the amilial
A. Hereditary nonpolyposis colorectal cancer (HNPCC) adenomatous polyposis (FAP) syndrome. A ter resolution o
B. Familial adenomatous polyposis (FAP) the colonic disease by total colectomy, patients with FAP must
C. Peutz-Jeghers syndrome be ollowed with periodic upper gastrointestinal (GI) endos-
D. Von Hippel-Lindau (VHL) syndrome copy to maintain surveillance or duodenal tumors. Duodenal
cancer is the leading cause o death among patients with FAP.
(See Schwartz 10th ed., p. 1158.)

19. Which o the ollowing statements is true regarding Answer: C


GIS s? GIS s are a orm o sarcoma which occur most commonly
A. Most occur in the small intestine. (70%) in the stomach. hey more requently present with GI
B. GIS s are usually metastatic when rst diagnosed. hemorrhage than other small bowel malignancies. hey are
C. GIS s typically present with GI hemorrhage. usually re ractory to conventional cytotoxic chemotherapy,
D. GIS s are usually responsive to cytotoxic chemotherapy. but are not usually metastatic on initial diagnosis. A radical
lymphadenectomy is not usually required; a segmental resec-
tion o the involved portion o the small intestine is usually
su icient surgical treatment. (See Schwartz 10th ed., p. 1162.)

20. Methods to prevent radiation enteritis o the small bowel Answer: D


during pelvic irradiation or gynecologic or rectal malig- In addition to limiting radiation exposure to less than 5000 cGy,
nancy include which o the ollowing? avoiding radiation to the small intestine a ter pelvic surgery
A. ilt table positioning in rendelenburg position dur- can involve steep rendelenburg positioning during radia-
ing radiation therapy treatments. tion therapy sessions, closure o the pelvic peritoneum at the
B. Closure (reapproximation) o the pelvic peritoneum level o the sacral promontory to prevent small bowel illing
af er primary resection. the pelvis, and creating o an absorbable mesh sling to prevent
C. Placement o an absorbable mesh sling to suspend the small intestine rom illing the pelvic cavity. (See Schwartz
small intestine out o the pelvis during postoperative 10th ed., p. 1163.)
radiation therapy.
D. All o the above.

21. What ectopic tissue is commonly ound in a Meckel Answer: A


diverticulum? Approximately 60% o Meckel diverticula contain ectopic tis-
A. Gastric mucosa sue, o which over 60% consists o gastric mucosa. Pancreatic
B. Ectopic pancreas acini are next most common, ollowed by pancreatic islets,
C. Splenic ollicles endometriosis, and hepatobiliary tissues. Gastric mucosa can
D. Ovarian ollicles ulcerate and bleed, the etiology o which can be hard to deter-
mine unless the Meckel diverticulum is known. (See Schwartz
10th ed., pp. 1163–1164).

22. A patient with recent onset o ascites af er an episode o Answer: C


acute pancreatitis undergoes paracentesis, which reveals Chylous ascites can develop as a complication o operative
cloudy white uid. What therapy is indicated? procedures or in lammatory conditions such as acute pan-
A. Surgical exploration creatitis. Lymphatic drainage rom damaged lymphatics can
B. Low- at diet heal when the patient is made NPO, and maintained on PN
C. otal parenteral nutrition ( PN) and octreotide and octreotide. Medium-chain triglycerides have been advo-
D. Octreotide and weekly paracentesis cated as an oral diet, but temporary cessation o oral eeding
and octreotide comprise the most success ul therapy. (See
Schwartz 10th ed., pp. 1169–1170.)
223
23. Short bowel syndrome has been arbitrarily de ned in Answer: B
adults as having a small intestine o less than what length? A unctional de inition, in which insu icient absorptive
A. 300 cm capacity results in diarrhea, dehydration, and malnutrition
B. 200 cm is more appropriate, but a standard de inition o short bowel
C. 100 cm syndrome o 200 cm has been used widely. (See Schwartz
D. 50 cm 10th ed., p. 1171.)

24. Common causes o short bowel syndrome include all o Answer: D


the ollowing EXCEP In adults, the common etiologies o short bowel syndrome
A. Mesenteric ischemia include mesenteric ischemia, malignancy, and Crohn’s dis-
B. Malignancy ease. In pediatric patients, common causes include intestinal
C. Crohn’s disease atresias, volvulus, and necrotizing enterocolitis. Radiation
D. Radiation enteritis enteritis usually involves isolated segments o small bowel o
less than 50% o total small intestinal length. (See Schwartz
10th ed., p. 1171.)

25. Af er an emergency operation or bowel in arction in Answer: D


which more than hal o the small intestine was removed Reducing gastric secretion with proton pump inhibitors or
and a jejunostomy created, high volume ostomy losses histamine-2 receptor antagonist, reducing gastroenteropan-
cause recurrent dehydration. Management o this condi- creatic secretions with octreotide, and inhibiting motility
tion includes which o the ollowing? with agents such as loperamide or diphenoxylate, are use ul
A. Proton pump inhibitors or histamine-2 receptor approaches to prevent dehydration as the short gut adapts to
antagonists its new length. otal parenteral nutrition is also o ten required.
B. Octreotide (See Schwartz 10th ed., p. 1171.)
C. Loperamide
D. All o the above

You might also like